HK1033267A1 - The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents - Google Patents

The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents

Info

Publication number
HK1033267A1
HK1033267A1 HK01103945A HK01103945A HK1033267A1 HK 1033267 A1 HK1033267 A1 HK 1033267A1 HK 01103945 A HK01103945 A HK 01103945A HK 01103945 A HK01103945 A HK 01103945A HK 1033267 A1 HK1033267 A1 HK 1033267A1
Authority
HK
Hong Kong
Prior art keywords
extracts
vitis vinifera
atherosclerotic agents
phospholipid complexes
treatment
Prior art date
Application number
HK01103945A
Other languages
English (en)
Inventor
Paolo Morazzoni
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK1033267A1 publication Critical patent/HK1033267A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK01103945A 1997-12-04 2001-06-08 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents HK1033267A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002690A IT1296920B1 (it) 1997-12-04 1997-12-04 Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
PCT/EP1998/007662 WO1999029331A1 (en) 1997-12-04 1998-11-30 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents

Publications (1)

Publication Number Publication Date
HK1033267A1 true HK1033267A1 (en) 2001-08-24

Family

ID=11378312

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103945A HK1033267A1 (en) 1997-12-04 2001-06-08 The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents

Country Status (23)

Country Link
US (1) US6297218B1 (xx)
EP (1) EP1035859B1 (xx)
JP (1) JP4456267B2 (xx)
KR (1) KR100567867B1 (xx)
CN (1) CN1126564C (xx)
AT (1) ATE258802T1 (xx)
AU (1) AU743031B2 (xx)
BR (1) BR9805813B1 (xx)
CA (1) CA2312795C (xx)
CZ (1) CZ299555B6 (xx)
DE (1) DE69821524T2 (xx)
DK (1) DK1035859T3 (xx)
ES (1) ES2214755T3 (xx)
HK (1) HK1033267A1 (xx)
HU (1) HU228109B1 (xx)
IT (1) IT1296920B1 (xx)
NO (1) NO324796B1 (xx)
PL (1) PL191023B1 (xx)
PT (1) PT1035859E (xx)
RU (1) RU2207866C2 (xx)
SI (1) SI1035859T1 (xx)
SK (1) SK284865B6 (xx)
WO (1) WO1999029331A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
JP2001122791A (ja) 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
JP4574788B2 (ja) * 2000-03-24 2010-11-04 協和発酵バイオ株式会社 プロアントシアニジン含有組成物
IT1320080B1 (it) * 2000-10-25 2003-11-18 Giuliani Spa Composizione per uso farmaceutico o dietetico.
FR2836337B1 (fr) * 2002-02-28 2004-11-19 Bio Serae Laboratoires Utilisation des polymeres procyanidoliques a titre d'agents inhibuteurs des alpha-amylases et application dans des compositions a visees dietetiques
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
BRPI0317883B8 (pt) * 2002-12-31 2021-05-25 Boehringer Ingelheim Int comprimido revestido com filme compreendendo um extrato de folhas de vinha vermelha
ITMI20031313A1 (it) * 2003-06-27 2004-12-28 Indena Spa Associazioni di agenti vasoprotettori e formulazioni che li contengono.
EP1550450A1 (en) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies
RU2367464C2 (ru) 2004-02-19 2009-09-20 Берингер Ингельхайм Интернациональ Гмбх Состав для лечения хронических венозных недостаточностей, содержащий водный экстракт листьев красного винограда и противовоспалительное средство
US20060088617A1 (en) * 2004-10-23 2006-04-27 Mccurry James M Chocolate composition and method for benefiting the cardiovascular system
AT501682A1 (de) 2005-01-14 2006-10-15 Hermine Dr Engl Verfahren zur herstellung einer wirkstoffmischung
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
EP2829277A1 (en) 2013-07-26 2015-01-28 Natac Biotech, S.L. Use of a-type proanthocyanidins in treating a mineralocorticoid receptor related disease
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092743A1 (en) * 1970-06-15 1972-01-28 Aquitaine Invest Pharma Complete extraction of total flavanol gomers from plats -peripheral - venous activity
GB1541469A (en) * 1976-12-01 1979-02-28 Inverni Della Beffa Spa Method of obtaining flavonolic oligomers
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
US5484594A (en) * 1988-06-28 1996-01-16 Tecnofarmaci S.P.A. Process for preparing grapeseed extracts enriched in procyanidol oligomers
FI955691A (fi) * 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet

Also Published As

Publication number Publication date
ES2214755T3 (es) 2004-09-16
NO324796B1 (no) 2007-12-10
IT1296920B1 (it) 1999-08-03
ATE258802T1 (de) 2004-02-15
PL340884A1 (en) 2001-03-12
EP1035859B1 (en) 2004-02-04
AU1562799A (en) 1999-06-28
WO1999029331A1 (en) 1999-06-17
CA2312795A1 (en) 1999-06-17
CZ299555B6 (cs) 2008-09-03
SI1035859T1 (en) 2004-04-30
PL191023B1 (pl) 2006-03-31
CN1126564C (zh) 2003-11-05
SK284865B6 (sk) 2006-01-05
US6297218B1 (en) 2001-10-02
DE69821524D1 (de) 2004-03-11
CN1280498A (zh) 2001-01-17
SK8272000A3 (en) 2000-11-07
RU2207866C2 (ru) 2003-07-10
CA2312795C (en) 2009-01-20
BR9805813A (pt) 1999-12-14
HUP0100522A3 (en) 2002-04-29
EP1035859A1 (en) 2000-09-20
JP4456267B2 (ja) 2010-04-28
HUP0100522A2 (hu) 2001-12-28
DK1035859T3 (da) 2004-05-17
CZ20002038A3 (cs) 2000-12-13
KR100567867B1 (ko) 2006-04-04
DE69821524T2 (de) 2005-01-05
KR20010024654A (ko) 2001-03-26
JP2001525370A (ja) 2001-12-11
AU743031B2 (en) 2002-01-17
NO20002827L (no) 2000-06-02
PT1035859E (pt) 2004-05-31
HU228109B1 (en) 2012-11-28
ITMI972690A1 (it) 1999-06-04
BR9805813B1 (pt) 2009-05-05
NO20002827D0 (no) 2000-06-02

Similar Documents

Publication Publication Date Title
HK1033267A1 (en) The use of phospholipid complexes of extracts of vitis vinifera as anti-atherosclerotic agents
PL330862A1 (en) Clinical application of proteinous kinase c in order to increase clinical effectiveness of anticarcinogenic pharmaco- and radiotherapy
AU6015298A (en) Lyophilizate of lipid complex of water insoluble porphyrins
CA2202531A1 (en) Lyophilizate of lipid complex of water insoluble camptothecins
AU8020698A (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
CZ20012134A3 (cs) Fosfolipidové komplexy
IL118218A (en) Pharmaceutical compositions containing sarcodictyins
EP1003370A4 (en) METHOD FOR INCREASING MAGNESIUM ABSORPTION AND PREVENTING ARTHEROSCLEROSIS
AU2193797A (en) Delivery of therapeutic agents to the prostate
NZ501641A (en) Ganglioside immunostimulating complexes and their use in treating cancer
EP0949928A4 (en) ADMINISTRATED ANDROGENS AND DIPHOSPHONE COMPOUNDS FOR TREATING DISEASES
AU8760298A (en) Coup-tfi directed therapies in the treatment of disease
AU4787097A (en) Improvements in or relating to diagnostic/therapeutic agents
AU4786797A (en) Improvements in or relating to diagnostic/therapeutic agents
AU1756299A (en) Use of putamen ovi
GEU1998402Y (en) Means for Treatment of Skin Cancer - “Khvedelidze Ointment”
GB9622368D0 (en) Improvements in or relating to diagnostic/therapeutic agents
UA10683A (uk) Засіб для лікувальhих ваhh
UA29506C2 (uk) Лікувально-косметичний засіб "фіто-пелоїд"
GB9622364D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9622365D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9622366D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9622367D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9622369D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9712879D0 (en) Hyperbaric lesion treatment

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131130